The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens.
Category: Shingles (Disease)
-
Eli Lilly to Buy 3 Vaccine Developers
The New York Times – Business: -
Shingles Vaccine Can Decrease Risk of Dementia, Study Finds
A growing body of research suggests that preventing the viral infection can help stave off cognitive decline.